Recommendations on insulin determination
DOI:
https://doi.org/10.47196/diab.v58i3.1142Keywords:
insulin determination, recommendation, insulin resistanceAbstract
Insulinemia measurement can provide useful information in certain research contexts, but its limitations in terms of variability, interpretation, cost and lack of standardization in the determination do not make it useful in clinical practice. This recommendations clarifies the reasons why insulinemia measurement is not currently recommended for the diagnosis and follow-up of patients with clinical suspicion of prediabetes, insulin resistance, metabolic syndrome and diabetes mellitus. Blood insulin levels can vary widely throughout the day and in response to food intake, exercise and other factors. Interpreting the results of a single insulin measurement can be complicated and does not provide an accurate conclusion of the patient's metabolic status.
References
I. Gagliardino JJ. Regulación y características de la secreción de insulina: su implicancia en la terapia de la diabetes tipo 2. Rev Soc Argent Diab 2000; 34(Sup1):10-22.
II. Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003;61(12):397-412. doi: 10.1301/nr.2003.dec.397-412.
III. Galicia-García U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21(17):6275. doi: 10.3390/ijms21176275.
IV. Staten MA, Stern MP, Miller WG, Steffes MW, Campbell SE; for the Insulin Standardization Workgroup. Insulin assay standardization. Diabetes Care 2010;33(1):205-6. doi: 10.2337/dc09-1206.
V. Hörber S, Achenbach P, Schleicher E, et al. Harmonization of immunoassays for biomarkers in diabetes mellitus. Biotechnol Adv 2020;39:107359. doi: 10.1016/j.biotechadv.2019.02.015.
VI. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark Å, et al. Executive summary. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2023;69(8):777-84. doi: 10.1093/clinchem/hvad079.
VII. Sharma VR, Matta ST, Haymond MW, Chung ST. Measuring insulin resistance in humans. Horm Res Paediatr 2020;93(11-12):577-88. doi: 10.1159/000515462.
VIII. Bosch X, Alfonso F, Bermejo J. Diabetes y enfermedad cardiovascular. Una mirada hacia la nueva epidemia del siglo
XXI. Rev Esp Cardiol 2002;55(5):525-7. Disponible en: https://www.revespcardiol.org/es-diabetes-enfermedad-cardiovascular-una-mirada-articulo-13031153.
IX. Lee S-H, Park S-Y, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J.2022;46(1):15-37. doi: 10.4093/dmj.2021.0280.
X. Crofts CA, Zinn C, Wheldon MC, Schofield GM. A unifying theory of hiperinsulinemia. Diabesity 2015;1(4):34. doi: 10.15562/diabesity.2015.19.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Diabetes

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.